Opioid δ-receptor Agonists Offer New Hope for IBS Treatment
A New Dawn for IBS Treatment: Targeting the Brain for relief Irritable bowel syndrome (IBS) affects over 10% of the global population, causing meaningful discomfort and impacting quality of life. While current treatments primarily focus on symptom management, a groundbreaking study published in the British Journal of Pharmacology offers a glimmer of hope: targeting the … Read more